Review Article
Salivary Biomarkers: Noninvasive Ways for Diagnosis of Parkinson’s Disease
Table 1
Biomarkers’ alteration in PD.
| Biomarkers | Technique | Result | Ref. |
| α‐syn | — | Present | [16] | α-Syn total | Luminex assay | — | [17] | Oligomeric α-Syn | Gel filtration chromatography/western blot | ↑ | Total Α-Syn | ELISA | ↓ | [18] | Oligomeric α-Syn | ELISA | ↑ | Oligo/total α-Syn | ELISA | ↑ | Total α-Syn | ELISA | ↓ | [19] | Oligomeric α-Syn | ELISA | ↑ | [20] | Oligomeric α-Syn | ELISA | ↑ | [21] | Total Α-Syn | ELISA | ↓ | [22] | Oligomeric α-Syn | Electrochemiluminescence | ↑ | [23] | Oligo/total α-Syn | Electrochemiluminescence | ↑ | Total α-Syn | Electrochemiluminescence | _ | α-SynPS129 | Electrochemiluminescence | _ | Oligo α-Syn | ELISA | ↑ | [24] | Oligo/total α-Syn | ELISA | ↑ | Fila-Syn/total Α-Syn | ELISA | ↑ | [25] | Total Α-Syn | Luminex assay | _ | [26] | Total α-Syn | Mass spectrometry | ↓ | [27] |
| DJ-1 | | | | DJ-1 | Luminex assay | ↑ | [26] | DJ-1 | Mass spectrometry | ↑ | [27] | DJ-1 | Immunoblotting | ↑ | [28] | DJ-1 | Western blotting | ↑ | [29] |
| Substance P | | | | Substance P | Radioimmunoassay | ↓ | [30] | Substance P | ELISA | ↓ | [31] | Substance P | ELISA | ↓ | [32] |
| Heme oxygenase-1 | | | | Heme oxygenase-1 | ELISA | ↑ | [33] | Heme oxygenase-1 | ELISA/western blotting | ↑ | [34] |
| Acetylcholinesterase | | | | Acetylcholinesterase | Colorimetric method | ↑ | [35] | Acetylcholinesterase | Colorimetric method | ↑ | [36] |
| Cortisol | | | | Cortisol | ELISA | ↑ | [37] | Cortisol | ELISA | ↓ | [38] | Cortisol | Luminescence immunoassay | ↑(morning) | [39] | Cortisol | Radioimmunoassay | ↑(morning) | [40] | Cortisol | — | ↑ | [41] |
| MicroRNA | | | | miR-153 | q-PCR | Downregulated | [42] | miR‐223 | q-PCR | Downregulated | miR-784 | q-PCR | Upregulated | [43] | miR-145-3p | q-PCR | Upregulated |
|
|